Selective cancer-germline gene expression in pediatric brain tumors

Journal of Neuro-Oncology

Volumn 88, Issue 3, 2008, Pages 273-280

  Jacobs, Joannes F M ^a   Grauer, Oliver M ^b,c   Brasseur, Francis ^d   Hoogerbrugge, Peter M ^a   Wesseling, Pieter ^a,e   Gidding, Corrie E ^a   Rakt, Mandy W M M ^c   Figdor, Carl G ^c   Coulie, Pierre G ^f   Vries, I Jolanda M ^a,c   Adema, Gosse J ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^f DE DUVE INSTITUTE   (Belgium)

Author keywords

Brain tumor; Immune target; MAGE; NY ESO 1; Pediatrics; qPCR

Indexed keywords

CANCER VACCINE; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 10; MELANOMA ANTIGEN 12; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MELANOMA ANTIGEN 6; MELANOMA ANTIGEN C2; NY ESO 1 ANTIGEN; PROTEIN GAGE 1,2,8; TUMOR ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN TUMOR; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CHOROID PLEXUS TUMOR; CONTROLLED STUDY; DRUG TARGETING; EPENDYMOMA; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC SELECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MEDULLOBLASTOMA; ONSET AGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 44649146376     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9577-6     Document Type: Article

References (36)

1. Linet MS, Ries LA, Smith MA et al (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051-1058
2. Ransohoff RM, Kivisakk P, Kidd G (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3:569-581
3. Galea I, Bernardes-Silva M, Forse PA et al (2007) An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med 204:2023-2030
4. Lampson LA (2003) Brain tumor immunotherapy: An immunologist's perspective. J Neurooncol 64:3-11
5. Khan-Farooqi HR, Prins RM, Liau LM (2005) Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies. Neurol Res 27:692-702
6. de Vleeschouwer S, Rapp M, Sorg RV et al (2006) Dendritic cell vaccination in patients with malignant gliomas: Current status and future directions. Neurosurgery 59:988-999 discussion 99-1000
7. Mackall CL, Fleisher TA, Brown MR et al (1995) Age, thymopoiesis, and CD4 + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143-149
8. Heitger A, Greinix H, Mannhalter C et al (2000) Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation 69:2366-2373
9. van der Bruggen P, Traversari C, Chomez P et al (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-1647
10. Van Der Bruggen P, Zhang Y, Chaux P et al (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188:51-64
11. Jacobs JF, Brasseur F, Hulsbergen-van de Kaa CA et al (2007) Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR. Int J Cancer 120:67-74
12. Raff T, van der Giet M, Endemann D et al (1997) Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 23:456-460
13. Zammatteo N, Lockman L, Brasseur F et al (2002) DNA microarray to monitor the expression of MAGE-A genes. Clin Chem 48:25-34
14. So T, Hanagiri T, Chapiro J et al (2007) Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules. Cancer Immunol Immunother 56:259-269
15. Kholmanskikh O, Loriot A, Brasseur F et al (2008) Expression of BORIS in melanoma: Lack of association with MAGE-A1 activation. Int J Cancer 122:777-784
16. Jungbluth AA, Chen YT, Stockert E et al (2001) Immunohistochemical analysis of NY-ESO-1 antigen in normal and malignant human tissues. Int J Cancer 92:856-860
17. Chen YT, Stockert E, Chen Y et al (1994) Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci USA 91:1004-1008
18. Kocher T, Schultz-Thater E, Gudat F et al (1995) Identification and intracellular location of MAGE-3 gene product. Cancer Res 55:2236-2239
19. Landry C, Brasseur F, Spagnoli GC et al (2000) Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer 86:835-841
20. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 114:97-109
21. Bodey B, Siegel SE, Kaiser HE (2002) MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression. In Vivo 16:583-588
22. Rimoldi D, Romero P, Carrel S (1993) The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 54:527-528
23. Chi DD, Merchant RE, Rand R et al (1997) Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 150:2143-2152
24. Sahin U, Koslowski M, Tureci O et al (2000) Expression of cancer testis genes in human brain tumors. Clin Cancer Res 6:3916-3922
25. Velders MP, Markiewicz MA, Eiben GL et al (2003) CD4+ T cell matters in tumor immunity. Int Rev Immunol 22:113-140
26. Kershaw MH, Trapani JA, Smyth MJ (1995) Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer. Ther Immunol 2:173-181
27. Boon T, Cerottini JC, Van den Eynde B et al (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337-365
28. Rosenberg SA (2001) Progress in human tumour immunology and immunotherapy. Nature 411:380-384
29. Kalos M (2003) Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects. Vaccine 21:781-786
30. Sinkovics JG, Horvath JC (2000) Vaccination against human cancers (review). Int J Oncol 16:81-96
31. Bodey B, Bodey B Jr, Siegel SE (1995) Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors. Mod Pathol 8:333-338
32. Simpson AJ, Caballero OL, Jungbluth A et al (2005) Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5:615-625
33. Litofsky NS, Hinton D, Raffel C (1994) The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery 34:967-972 discussion 72-73
34. Sure U, Ruedi D, Tachibana O et al (1997) Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 56:782-789
35. Rickert CH, Strater R, Kaatsch P et al (2001) Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 158:1525-1532
36. Szybka M, Bartkowiak J, Zakrzewski K et al (2003) Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients. Clin Neuropathol 22:180-186